Literature DB >> 646452

Serum 25-hydroxyvitamin D levels in thalassaemia.

S Tsitoura, N Amarilio, P Lapatsanis, S Pantelakis, S Doxiadis.   

Abstract

Serum 25-hydroxyvitamin D levels were measured in 36 thalassaemic children and 27 controls aged 5-15 years. Blood specimens were collected from the beginning of April until the end of October 1976. We considered as the winter period the first 3 months and the summer period the last 4 months. We found that (a) thalassaemic children had lower levels of serum 25-hydroxyvitamin D than controls: (b) there was a seasonal variation of serum 25-hydroxyvitamin D in both groups; and (c) the thalassaemic children had malabsorption of vitamin D. We suggest that the bone lesions in thalassaemic children are related to vitamin D deficiency.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 646452      PMCID: PMC1544887          DOI: 10.1136/adc.53.4.347

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  The effect of hepatectomy on the synthesis of 25-hydroxyvitamin D3.

Authors:  E B Olson; J C Knutson; M H Bhattacharyya; H F DeLuca
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

2.  The transporting proteins of cholecalciferol and 25-hydroxycholecalciferol in serum of chicks and other species. Partial purification and characterization of the chick proteins.

Authors:  S Edelstein; D E Lawson; E Kodicek
Journal:  Biochem J       Date:  1973-11       Impact factor: 3.857

3.  Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis.

Authors:  J E Compston; R P Thompson
Journal:  Lancet       Date:  1977-04-02       Impact factor: 79.321

4.  Serum-25-hydroxy-vitamin-D in untreated parenchymal and cholestatic liver disease.

Authors:  R G Long; R K Skinner; M R Wills; S Sherlock
Journal:  Lancet       Date:  1976-09-25       Impact factor: 79.321

5.  25-Hydroxylation of vitamin D in primary biliary cirrhosis.

Authors:  R K Skinner; S Sherlock; R G Long; M R Wilis
Journal:  Lancet       Date:  1977-04-02       Impact factor: 79.321

6.  Comparison of vitamin D and 25-hydroxy-vitamin-D in the therapy of primary biliary cirrhosis.

Authors:  J B Wagonfeld; B A Nemchausky; M Bolt; J V Horst; J L Boyer; I H Rosenberg
Journal:  Lancet       Date:  1976-08-21       Impact factor: 79.321

  6 in total
  6 in total

1.  Impaired bone formation and osteopenia in heterozygous β(IVSII-654) knockin thalassemic mice.

Authors:  Kanogwun Thongchote; Saovaros Svasti; Mayurachat Sa-ardrit; Nateetip Krishnamra; Suthat Fucharoen; Narattaphol Charoenphandhu
Journal:  Histochem Cell Biol       Date:  2011-06-09       Impact factor: 4.304

2.  Parathyroid hormone, calcitonin and vitamin D metabolites in beta-thalassaemia major.

Authors:  G Zamboni; P Marradi; F Tagliaro; R Dorizzi; L Tatò
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

3.  Serum 1,25 dihydroxyvitamin D and osteocalcin concentrations in thalassaemia major.

Authors:  P Dandona; R K Menon; S Houlder; M Thomas; A V Hoffbrand; D M Flynn
Journal:  Arch Dis Child       Date:  1987-05       Impact factor: 3.791

4.  Growth Parameters and Vitamin D status in Children with Thalassemia Major in Upper Egypt.

Authors:  Fahim M Fahim; Khaled Saad; Eman A Askar; Eman Nasr Eldin; Ahmed F Thabet
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2013

5.  Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran.

Authors:  Alireza Abdollah Shamshirsaz; Mir Reza Bekheirnia; Mohammad Kamgar; Nima Pourzahedgilani; Navid Bouzari; Mohammadreza Habibzadeh; Reza Hashemi; Amirhooshang Abdollah Shamshirsaz; Shahriar Aghakhani; Hooman Homayoun; Bagher Larijani
Journal:  BMC Endocr Disord       Date:  2003-08-12       Impact factor: 2.763

6.  Biochemical Markers of Bone Turnover in Patients with β-Thalassemia Major: A Single Center Study from Southern Pakistan.

Authors:  Sadia Sultan; Syed Mohammed Irfan; Syed Ijlal Ahmed
Journal:  Adv Hematol       Date:  2016-02-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.